Flexion Therapeutics Announces Publication of Pooled Analysis of Phase 2/3 Data on Use of Rescue Medication with ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)

World News: . []

BURLINGTON Mass May 10 2019 GLOBE NEWSWIRE -- Flexion Therapeutics Inc NasdaqFLXN today LINK  that a pooled analysis of data from three Phase 23 randomized LINK  trials on the use of rescue medications with LINK  triamcinolo ne acet...

More news and information about Flexion Therapeutics, Inc.

Published By:

Globe Newswire: 12:30 GMT Friday 10th May 2019

Published: .

Search for other references to "flexion" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us